EP3645662B1 - Dérives du 2,3-dihydrobenzothiophène - Google Patents

Dérives du 2,3-dihydrobenzothiophène Download PDF

Info

Publication number
EP3645662B1
EP3645662B1 EP18732360.5A EP18732360A EP3645662B1 EP 3645662 B1 EP3645662 B1 EP 3645662B1 EP 18732360 A EP18732360 A EP 18732360A EP 3645662 B1 EP3645662 B1 EP 3645662B1
Authority
EP
European Patent Office
Prior art keywords
och
replaced
atoms
formula
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP18732360.5A
Other languages
German (de)
English (en)
Other versions
EP3645662A1 (fr
Inventor
Dmitry USHAKOV
Helga Haas
Thorsten vom Stein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of EP3645662A1 publication Critical patent/EP3645662A1/fr
Application granted granted Critical
Publication of EP3645662B1 publication Critical patent/EP3645662B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00—Liquid crystal materials
    • C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06—Non-steroidal liquid crystal compounds
    • C09K19/34—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3491—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having sulfur as hetero atom
    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60—Organic compounds having low molecular weight
    • H10K85/649—Aromatic compounds comprising a hetero atom
    • H10K85/655—Aromatic compounds comprising a hetero atom comprising only sulfur as heteroatom

Definitions

  • the present invention relates to 2,3-dihydrobenzothiophene derivatives, to the use thereof in liquid-crystalline or mesogenic media, to liquid-crystalline or mesogenic media comprising these derivatives, and to electro-optical display elements containing these liquid-crystalline or mesogenic media.
  • Liquid crystals have found widespread use since the first commercially usable liquid-crystalline compounds were found about 30 years ago.
  • Known areas of application are, in particular, displays for watches and pocket calculators, and large display panels as used in railway stations, airports and sports arenas. Further areas of application are displays of portable computers and navigation systems and video applications. For the last-mentioned applications in particular, high demands are made of the response times and contrast of the images.
  • the spatial arrangement of the molecules in a liquid crystal has the effect that many of its properties are direction-dependent.
  • optical, dielectric and elastomechanical anisotropies are the optical, dielectric and elastomechanical anisotropies.
  • the dielectric constant ⁇ of the liquid-crystalline medium has different values for the two orientations.
  • Substances whose dielectric constant is larger when the longitudinal axes of the molecules are oriented perpendicular to the capacitor plates than when they are oriented parallel are known as being dielectrically positive.
  • Most liquid crystals used in conventional displays fall into this group.
  • the dipole moment oriented along the longitudinal axis of the molecules is larger than the dipole moment oriented perpendicular to the longitudinal axis of the molecules.
  • the orientation of the larger dipole moment along the longitudinal axis of the molecule also determines the orientation of the molecule in a liquid-crystal display in the field-free state.
  • TN twisted nematic
  • a liquid-crystalline layer with a thickness of only from about 5 to 10 ⁇ m is arranged between two flat glass plates, onto each of which an electrically conductive, transparent layer of tin oxide or indium tin oxide has been vapour-deposited as electrode.
  • a likewise transparent alignment layer is located between these films and the liquid-crystalline layer.
  • This alignment layer serves to bring the longitudinal axes of the adjacent crystalline molecules into a preferential direction through surface forces in such a way that, in the voltage-free state, they lie uniformly on the inside of the display surface with the same alignment in a flat manner or with the same small tilt angle.
  • Two polarisation films which only enable linear-polarised light to enter and escape are adhesively bonded to the outside of the display in a certain arrangement.
  • IPS in-plane switching
  • FFS farnesoid-field switching
  • FFS displays have a low viewing-angle dependence of the contrast.
  • FFS displays usually contain an LC medium with positive dielectric anisotropy, and an alignment layer, usually of polyimide, which provides planar alignment to the molecules of the LC medium.
  • An object of the present invention was to provide compounds having advantageous properties for use in liquid-crystalline media.
  • a further object of the present invention is to provide liquid-crystalline media, in particular for use in VA, IPS or FFS displays.
  • the compounds of formula I are seleced from compounds of the sub-formula Ia wherein the occurring groups and parameters have the meanings given above and is selected from the group consisting of trans-1,4-cyclohexylene, 1,4-cyclohexenylene, and decaline-2,6-diyl, in which one or more non-adjacent CH 2 groups may be replaced by -O- and/or -S- and in which one or more H atoms may be replaced by F, and preferably has the meaning given for and independently of one another, are selected from the group consisting of 1,4-phenylene and 2,6-naphthylene, in which one or two CH groups may be replaced by N and in which, in addition, one or more H atoms may be replaced by F, Cl, or CF 3 , and m, p and q independently of one another, are 0 or 1.
  • Preferred compounds of formula Ia are selected from the following sub-formulae: wherein R 11 , R 21 , R 22 , Y, A 21 and A 22 have the meanings indicated above and preferably
  • the compounds of formula I are seleced from compounds of the sub-formula Ib wherein the occurring groups and parameters have the meanings given above for formula I, and is selected from the group consisting of 1,4-phenylene and 2,6-naphthylene, in which one or two CH groups may be replaced by N and in which, in addition, one or more H atoms may be replaced by F, Cl or CF 3 , and preferably has the meaning given for and alternatively is selected from the group consisting of trans-1,4-cyclohexylene, 1,4-cyclohexenylene, and decaline-2,6-diyl, in which one or more non-adjacent CH 2 groups may be replaced by -O- and/or -S- and in which one or more H atoms may be replaced by F, and independently of one another, have the meaning given for and m, p and q independently of one another, are 0 or 1.
  • Preferred compounds of formula Ib are wherein R 11 , R 21 , R 22 , Y, A 21 and A 22 have the meanings indicated above and preferably
  • the compounds according to the invention all have negative ⁇ and are therefore suitable, in particular, for use in VA-TFT displays, and in IPS- and FFS displays.
  • the compounds according to the invention preferably have a ⁇ of ⁇ -2.5, more preferably of ⁇ -5 and particularly preferably a ⁇ of ⁇ -8. They exhibit very good compatibility with the conventional substances used in liquid-crystal mixtures for displays.
  • trans-1,4-cyclohexylene denote 1,4-phenylene.
  • R 11 , R 21 , R 22 and L are an alkyl radical and/or an alkoxy radical, this can be straight-chain or branched. It is preferably straight-chain, has 2, 3, 4, 5, 6 or 7 carbon atoms and accordingly is preferably ethyl, propyl, butyl, pentyl, hexyl, heptyl, ethoxy, propoxy, butoxy, pentoxy, hexoxy or heptoxy, furthermore methyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, methoxy, octoxy, nonoxy, decoxy, undecoxy, dodecoxy, tridecoxy or tetradecoxy.
  • R 11 , R 21 , R 22 and L may each, independently of one another, be an alkenyl radical having from 2 to 15 carbon atoms, which may be straight-chain or branched. It is preferably straight-chain and has from 2 to 7 carbon atoms. Accordingly, it is preferably vinyl, prop-1- or -2-enyl, but-1-, -2- or -3-enyl, pent-1-, -2-, -3- or -4-enyl, hex-1-, -2-, -3-, -4- or -5-enyl, or hept-1-, -2-, -3-, -4-, -5- or -6-enyl.
  • R 11 , R 21 , R 22 and L may each, independently of one another, be an alkyl radical having from 1 to 15 carbon atoms in which one CH 2 group has been replaced by -O- and one has been replaced by -CO-, where these are preferably adjacent. This thus contains an acyloxy group -CO-O- or an oxycarbonyl group -O-CO-. This is preferably straight-chain and has from 2 to 6 carbon atoms.
  • R 11 , R 21 , R 22 and L may each, independently of one another, be an alkyl radical having from 1 to 15 carbon atoms or alkenyl radical having from 2 to 15 carbon atoms, each of which is monosubstituted by -CN or -CF 3 and is preferably straight-chain. The substitution by -CN or -CF 3 is possible in any desired position.
  • R 11 , R 21 , R 22 and L may each, independently of one another, be an alkyl radical in which two or more CH 2 groups have been replaced by -O- and/or -CO-O-, where this may be straight-chain or branched. It is preferably branched and has from 3 to 12 carbon atoms.
  • R, L 2 , L 3 , L 4 and L 6 may each, independently of one another, be an alkyl radical having from 1 to 15 carbon atoms or an alkenyl radical having from 2 to 15 carbon atoms, each of which is at least monosubstituted by halogen, where these radicals are preferably straight-chain and halogen is preferably -F or -CI. In the case of polysubstitution, halogen is preferably -F.
  • the resultant radicals also include perfluorinated radicals, such as -CF 3 . In the case of monosubstitution, the fluorine or chlorine substituent can be in any desired position, but is preferably in the ⁇ -position.
  • the compounds of the general formula I are prepared by methods known per se, as described in the literature (for example in the standard works, such as Houben-Weyl, Methoden der organischen Chemie [Methods of Organic Chemistry], Georg-Thieme-Verlag, Stuttgart), to be precise under reaction conditions which are known and are suitable for the said reactions. Use can be made here of variants which are known per se, but are not mentioned here in greater detail.
  • the starting materials can also be formed in situ by not isolating them from the reaction mixture, but instead immediately converting them further into the compounds of the general formula I
  • the compounds of formula I are preferably synthesized as shown in schemes 1 and 2.
  • Aldehydes 2 are synthesised by orthometallation of fluorobenzenes (1) followed by formylation with e.g. N-formylpiperidine.
  • Knoevenagel condensation with methyl mercaptoacetate and intramolecular nucleophiolic replacement of fluoride yields benzothiophene carboxylic acid esters 3 which can be saponified to give carboxylic acids 4.
  • the latter undergo decarboxylation when heated in quinoline in the presence of copper.
  • the resulting benzothiophene (5) can be metallated with butyllithium to give key intermediate 6.
  • Key intermediate 6 is further transferred into derivatives according to the invention by a variety of reactions, e.g. addition to carbonyl compounds or transition metal catalysed cross coupling reactions with aromatic halides.
  • Such a transformation is exemplified by the reaction with a cyclohexanone derivative (7) to give alcohols 8, which can be dehydrated and hydrogenated to give benzothiophenes 9 (scheme 2).
  • the double bond in the thiophene ring is not hydrogenated in this synthetic step.
  • This reaction is performed in a last step of the synthesis to give diydrobenzothiophenes 10.
  • Another object of the present invention is a process of the preparation of a compound of formula I by hydrogenation of a compound of formula II in which the occurring groups and parameters have the meanings indicated above for formula I.
  • the compounds of the general formula I can be used in liquid-crystalline media.
  • the present invention therefore also relates to a liquid-crystalline medium comprising two or more liquid-crystalline compounds, comprising one or more compounds of the general formula I.
  • the present invention also relates to liquid-crystalline media comprising from 2 to 40, preferably from 4 to 30, components as further constituents besides one or more compounds of the formula I according to the invention. These media particularly preferably comprise from 7 to 25 components besides one or more compounds according to the invention.
  • nematic or nematogenic (monotropic or isotropic) substances are preferably selected from nematic or nematogenic (monotropic or isotropic) substances, in particular substances from the classes of the azoxy-benzenes, benzylideneanilines, biphenyls, terphenyls, phenyl or cyclohexyl benzoates, phenyl or cyclohexyl esters of cyclohexanecarboxylic acid, phenyl or cyclohexyl esters of cyclohexylbenzoic acid, phenyl or cyclohexyl esters of cyclohexylcyclohexanecarboxylic acid, cyclohexylphenyl esters of benzoic acid, of cyclohexanecarboxylic acid or of cyclohexylcyclohexanecarboxylic acid, phenylcyclohexanes, cycl
  • L and E which may be identical or different, are each, independently of one another, a divalent radical from the group formed by -Phe-, -Cyc-, -Phe-Phe-, -Phe-Cyc-, -Cyc-Cyc-, -Pyr-, -Dio-, -G-Phe- and -G-Cyc- and their mirror images, where Phe is unsubstituted or fluorine-substituted 1,4-phenylene, Cyc is trans-1,4-cyclohexylene or 1,4-cyclohexenylene, Pyr is pyrimidine-2,5-diyl or pyridine-2,5-diyl, Dio is 1,3-dioxane-2,5-diyl, and G is 2-(trans-1,4-cyclohexyl)ethyl.
  • One of the radicals L and E is preferably Cyc or Phe. E is preferably Cyc, Phe or Phe-Cyc.
  • the media according to the invention preferably comprise one or more components selected from the compounds of the formulae (1), (2), (3), (4) and (5) in which L and E are selected from the group consisting of Cyc and Phe and simultaneously one or more components selected from the compounds of the formulae (1), (2), (3), (4) and (5) in which one of the radicals L and E is selected from the group consisting of Cyc and Phe and the other radical is selected from the group consisting of -Phe-Phe-, -Phe-Cyc-, -Cyc-Cyc-, -G-Phe- and -G-Cyc-, and optionally one or more components selected from the compounds of the formulae (1), (2), (3), (4) and (5) in which the radicals L and E are selected from the group consisting of -Phe-Cyc-, -Cyc-Cyc
  • R' and R" are each, independently of one another, alkyl, alkenyl, alkoxy, alkoxyalkyl, alkenyloxy or alkanoyloxy having up to 8 carbon atoms.
  • This smaller sub-group is called group A below, and the compounds are referred to by the sub-formulae (1a), (2a), (3a), (4a) and (5a).
  • R' and R" are different from one another, one of these radicals usually being alkyl, alkenyl, alkoxy or alkoxyalkyl.
  • R' and R" are as defined for the compounds of the sub-formulae (1a) to (5a) and are preferably alkyl, alkenyl, alkoxy or alkoxyalkyl.
  • R" is -CN.
  • This sub-group is referred to below as group C, and the compounds of this sub-group are correspondingly described by sub-formulae (1c), (2c), (3c), (4c) and (5c).
  • R' is as defined for the compounds of the sub-formulae (1a) to (5a) and is preferably alkyl, alkenyl, alkoxy or alkoxyalkyl.
  • the media according to the invention preferably comprise one or more compounds selected from groups A, B and/or C.
  • the proportions by weight of the compounds from these groups in the media according to the invention are: group A: from 0 to 90%, preferably from 20 to 90%, in particular from 30 to 90% group B: from 0 to 80%, preferably from 10 to 80%, in particular from 10 to 70% group C: from 0 to 80%, preferably from 5 to 80%, in particular from 5 to 50%.
  • the media according to the invention preferably comprise from 1 to 40%, particularly preferably from 5 to 30%, of the compounds of the formula I according to the invention. Preference is furthermore given to media comprising more than 40%, in particular from 45 to 90%, of compounds of the formulae formula I according to the invention.
  • the media preferably comprise three, four or five compounds of the formula I according to the invention.
  • the media according to the invention are prepared in a manner conventional per se.
  • the components are dissolved in one another, advantageously at elevated temperature.
  • the liquid-crystalline phases of the present invention can be modified in such a way that they can be used in all types of liquid-crystal display elements that have been disclosed hitherto.
  • Additives of this type are known to the person skilled in the art and are described in detail in the literature ( H. Kelker/R. Hatz, Handbook of Liquid Crystals, Verlag Chemie, Wein-heim, 1980 ).
  • pleochroic dyes can be used for the preparation of coloured guest-host systems or substances can be added in order to modify the dielectric anisotropy, the viscosity and/or the alignment of the nematic phases.
  • the present invention also relates to electro-optical liquid-crystal display elements containing a liquid-crystalline medium according to the invention.
  • ⁇ n denotes the optical anisotropy (589 nm, 20°C) and ⁇ denotes the dielectric anisotropy (1 kHz, 20°C).
  • ⁇ and ⁇ n values of the compounds according to the invention are obtained by extrapolation from liquid-crystalline mixtures consisting of 10% of the respective compound according to the invention and 90% of the commercially available liquid-crystal mixture ZLI-2857 (for ⁇ ) or ZLI-4792 (for ⁇ n) (Merck KGaA, Darmstadt). In cases of limited solubility, the compound is measured in a mixture comprising only 5% of the compound, which is noted by the addition (5%) after the values in question.
  • a solution of BuLi (15% in hexane, 140 mL, 0.219 mol) is added dropwise to a stirred solution of 1-butoxy-2,3-difluorobenzene (40.0 g, 0.215 mol) in THF (160 mL) at -70 °C.
  • the mixture is stirred for 30 min at the same temperature before it is treated with a solution of N-formylpiperidine (24.5 mL, 0.221 mol) in THF (80 mL).
  • the reaction mixture is allowed to warm to -30°C, treated with water and conc. HCl (until pH 6).
  • the aqueous phase is separated and extracted with MTB ether (2 times).
  • a solution of BuLi (15% in hexane, 30.8 mL, 49.0 mmol) is added dropwise to a solution of 6-butoxy-7-fluoro-benzothiophene (10.0 g, 44.5 mmol) in THF (40 mL) at -70 °C.
  • the mixture is stirred for 1 h at the same temperature before a solution of 4-propylcyclohexanone (7.5 g, 53.5 mmol) in THF (10 mL) is added.
  • the reaction mixture is stirred for 1 hat -70 °C before it is allowed to warm to room temperature, quenched with sat. ammonium chloride solution, extracted with MTB ether, dried over Na 2 SO 4 , filtered and concentrated under reduced pressure.
  • reaction mixture is concentrated under reduced pressure and purified by flash chromatography (heptane/chlorobutane), followed by recrystallization from heptane to give 6-butoxy-7-fluoro-2-(4-propylcyclohexyl)-2,3-dihydrobenzothiophene as colourless crystals.
  • the compounds are distinguished by a high negative dielectric anisotropy and high clearing temperatures which makes them very suitable for applications in liquid crystalline media for VA, IPS and FFS displays.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Liquid Crystal Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Claims (12)

  1. Composé de la formule I
    Figure imgb1244
     dans laquelle
    R11, R21 et R22 représentent chacun, de manière identique ou différente, F, Cl, Br, I, CN, SCN, OH, SF5, alkyle en chaîne droite ou ramifié qui comporte jusqu'à 15 atomes de C, lequel peut être non substitué, mono- ou polysubstitué par F, Cl, Br, I ou CN étant entendu qu'il est également possible qu'un ou plusieurs groupe(s) CH2 non adjacents soit/soient remplacé(s), dans chaque cas de manière indépendante les uns des autres, par
    Figure imgb1245
    Figure imgb1246
     -O-, -S-, -NH-, -C(O)-, -C(O)O-, -OC(O)-, -OC(O)O-, -S-C(O)-, -CO-S-, -CH=CH- ou -C≡C- de telle sorte que des atomes de O et/ou de S ne soient pas directement liés les uns aux autres,
    A11, A12 A21 et A22 représentent chacun, de manière indépendante les uns des autres, un radical qui est sélectionné parmi les groupes qui suivent :
    a) le groupe qui est constitué par trans-1,4-cyclohexylène, 1,4-cyclohexénylène, et décaline-2,6-diyle, où un ou plusieurs groupe(s) CH2 non adjacents peut/peuvent être remplacé(s) par -O- et/ou par -S- et où un ou plusieurs atome(s) de H peut/ peuvent être remplacé(s) par F,
    b) le groupe qui est constitué par 1,4-phénylène et 2,6-naphtylène, où un ou deux groupe(s) CH peut/peuvent être remplacé(s) par N et où, en outre, un ou plusieurs atome(s) de H peut/peuvent être remplacé(s) par L,
    c) le groupe qui est constitué par 1,3-dioxane-2,5-diyle, tétrahydrofuran-2,5-diyle, cyclobutane-1,3-diyle, thiophène-2,5-diyle, sélénophène-2,5-diyle et 1,2,3,4-tétrahydronanaphtaline-2,6-diyle, dont chacun peut être mono- ou polysubstitué par L,
    d) le groupe qui est constitué par bicyclo[1.1.1]pentane-1,3-diyle, bicyclo[2.2.2]octane-1,4-diyle, et spiro[3.3]heptane-2,6-diyle, où un ou plusieurs atome(s) de H peut/peuvent être remplacé(s) par F
    L représentent chacun, de manière identique ou différente, un groupe halogène, cyano, alkyle, alcoxy, alkylcarbonyle ou alcoxycarbonyle qui comporte de 1 à 7 atome(s) de C, où un ou plusieurs atome(s) de H peut/peuvent être substitué(s) par F ou par Cl,
    Z11 et Z12 représentent, de manière indépendante l'un de l'autre, une liaison simple, -CF2O-, -OCF2-, -CH2CH2-, -CF2CF2-, -C(O)O-, -OC(O)-, -CH2O-, -OCH2-, -CF=CH-, -CH=CF-, -CF=CF-, -CH=CH- ou -C≡C-, de préférence -CH2CH2-, -CF2CF2-, -CH=CH- ou une liaison simple,
    Y représente H, F, Cl, CF3, ou OCF3, de préférence F,
    m et n sont, de manière indépendante l'un de l'autre, 0, 1 ou 2, étant entendu qu'au moins l'un de m et n représente 0.
  2. Composé de la formule I selon la revendication 1, dans lequel le composé est sélectionné parmi les composés de la sous-formule la
    Figure imgb1247
     dans laquelle les groupes et les paramètres rencontrés présentent les significations qui ont été données selon la revendication 1, et
    Figure imgb1248
     est sélectionné parmi le groupe qui est constitué par trans-1,4-cyclohexylène, 1,4-cyclohexénylène, et décaline-2,6-diyle, où un ou plusieurs groupe(s) CH2 non adjacents peut/peuvent être remplacé(s) par -O- et/ou par -S- et où un ou plusieurs atome(s) de H peut/peuvent être remplacé(s) par F.
  3. Composé de la formule I selon la revendication 1, dans lequel le composé est sélectionné parmi les composés de la sous-formule Ib
    Figure imgb1249
     dans laquelle les groupes et les paramètres rencontrés présentent les significations qui ont été données selon la revendication 1, et
    Figure imgb1250
     est sélectionné parmi le groupe qui est constitué par 1,4-phénylène et 2,6-naphtylène, où un ou deux groupe(s) CH peut/peuvent être remplacé(s) par N et où, en outre, un ou plusieurs atome(s) de H peut/peuvent être remplacé(s) par F, Cl ou CF3.
  4. Composé de la formule I selon une ou plusieurs des revendications 1 à 3, dans lequel Z11 et Z12 représentent une liaison simple.
  5. Composé de la formule I selon une ou plusieurs des revendications 1, 2 et 4, sélectionné parmi le groupe de composés des sous-formules
    Figure imgb1251
    Figure imgb1252
    Figure imgb1253
    Figure imgb1254
    Figure imgb1255
    Figure imgb1256
    Figure imgb1257
    Figure imgb1258
    Figure imgb1259
    Figure imgb1260
    Figure imgb1261
    Figure imgb1262
    Figure imgb1263
    Figure imgb1264
    Figure imgb1265
     dans lesquelles R11, R21, R22, Y, A21 et A22 présentent les significations qui ont été indiquées selon la revendication 1.
  6. Composé de la formule I selon une ou plusieurs des revendications 1, 3 et 4, sélectionné parmi le groupe de composés des sous-formules
    Figure imgb1266
    Figure imgb1267
    Figure imgb1268
    Figure imgb1269
    Figure imgb1270
    Figure imgb1271
    Figure imgb1272
    Figure imgb1273
    Figure imgb1274
    Figure imgb1275
    Figure imgb1276
    Figure imgb1277
    Figure imgb1278
    Figure imgb1279
    Figure imgb1280
    Figure imgb1281
    Figure imgb1282
    Figure imgb1283
    Figure imgb1284
    Figure imgb1285
    Figure imgb1286
    Figure imgb1287
    Figure imgb1288
    Figure imgb1289
    Figure imgb1290
    Figure imgb1291
    Figure imgb1292
    Figure imgb1293
    Figure imgb1294
    Figure imgb1295
    Figure imgb1296
    Figure imgb1297
    Figure imgb1298
     dans lesquelles R11, R21, R22, Y, A21 et A22 présentent les significations qui ont été indiquées selon la revendication 1.
  7. Composé de la formule I selon une ou plusieurs des revendications 1 à 6 dans lequel
    Figure imgb1299
     et
    Figure imgb1300
     sont sélectionnés, de manière indépendante l'un de l'autre, parmi le groupe qui est constitué par 1,4-phénylène et 2,6-naphtylène, où un ou deux groupe(s) CH peut/peuvent être remplacé(s) par N et où, en outre, un ou plusieurs atome(s) de H peut/peuvent être remplacé(s) par F, Cl ou CF3.
  8. Composé selon une ou plusieurs des revendications 1 à 7, dans lequel
    R11 représente alkyle, alkényle ou alcoxy qui comporte jusqu'à 7 atomes de C, où un ou plusieurs atome(s) de H peut/peuvent être remplacé(s) par fluor, et
    R21 et R22 représentent, de manière indépendante l'un de l'autre, alkyle, alkényle ou alcoxy qui comporte jusqu'à 7 atomes de F, Cl, CN, SCN, SF5, CF3, OCF3, OCF2H, OCHF2, ou -OCH=CF2.
  9. Procédé pour la préparation de composés de la formule I selon la revendication 1, caractérisé en ce qu'un composé de la formule II
    Figure imgb1301
     dans laquelle les groupes et les paramètres rencontrés présentent les significations qui ont été indiquées pour la formule I selon la revendication 1,
    est hydrogéné en présence d'un catalyseur.
  10. Utilisation d'un composé selon une ou plusieurs des revendications 1 à 8 dans les milieux cristallins liquides.
  11. Milieu cristallin liquide comprenant deux composés cristallins liquides ou plus, caractérisé en ce qu'il comprend un ou plusieurs composé(s) selon une ou plusieurs des revendications 1 à 8.
  12. Élément d'affichage électrooptique contenant un milieu cristallin liquide selon la revendication 11.
EP18732360.5A 2017-06-28 2018-06-25 Dérives du 2,3-dihydrobenzothiophène Active EP3645662B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17178476 2017-06-28
PCT/EP2018/066935 WO2019002196A1 (fr) 2017-06-28 2018-06-25 Dérives du 2,3-dihydrobenzothiophène

Publications (2)

Publication Number Publication Date
EP3645662A1 EP3645662A1 (fr) 2020-05-06
EP3645662B1 true EP3645662B1 (fr) 2021-03-24

Family

ID=59253411

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18732360.5A Active EP3645662B1 (fr) 2017-06-28 2018-06-25 Dérives du 2,3-dihydrobenzothiophène

Country Status (6)

Country Link
US (1) US11174432B2 (fr)
EP (1) EP3645662B1 (fr)
KR (1) KR20200024242A (fr)
CN (1) CN110799627B (fr)
TW (1) TWI772448B (fr)
WO (1) WO2019002196A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019002196A1 (fr) * 2017-06-28 2019-01-03 Merck Patent Gmbh Dérives du 2,3-dihydrobenzothiophène
CN116948657A (zh) * 2023-06-28 2023-10-27 北京燕化集联光电技术有限公司 液晶化合物、组合物及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816473A (en) * 1983-07-14 1989-03-28 Syntex (U.S.A.) Inc. Aroyl benzofuran and benzothiophene acetic and propionic acids
JPS61158976A (ja) * 1984-12-28 1986-07-18 Shionogi & Co Ltd ベンゾフランおよびベンゾチオフエン誘導体
DE102004053279A1 (de) 2003-11-25 2005-06-23 Merck Patent Gmbh Benzofuran- und Benzothiophen-Derivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung
WO2015101928A1 (fr) 2013-12-31 2015-07-09 Aurigene Discovery Technologies Limited Dérivés de thiophène et de thiazole fusionnés utilisés en tant que modulateurs gamma ror
DE102016003902A1 (de) * 2015-04-13 2016-10-13 Merck Patent Gmbh Fluorierte Dibenzofuran- und Dibenzothiophenderivate
WO2019002196A1 (fr) * 2017-06-28 2019-01-03 Merck Patent Gmbh Dérives du 2,3-dihydrobenzothiophène

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
CN110799627B (zh) 2023-07-07
KR20200024242A (ko) 2020-03-06
EP3645662A1 (fr) 2020-05-06
US20200123444A1 (en) 2020-04-23
TWI772448B (zh) 2022-08-01
TW201904953A (zh) 2019-02-01
WO2019002196A1 (fr) 2019-01-03
CN110799627A (zh) 2020-02-14
US11174432B2 (en) 2021-11-16

Similar Documents

Publication Publication Date Title
US10017695B2 (en) Fluorinated dibenzofuran and dibenzothiophene derivatives
US9512102B2 (en) 4,6-difluorodibenzothiophene derivatives
US7514127B2 (en) Dibenzofuran derivatives, dibenzothiophene derivatives and fluorene derivatives
US20210284911A1 (en) Electro-Optical Display Elements
US11236063B2 (en) Dibenzofuran derivatives and dibenzothiophene derivatives
US20040171866A1 (en) Indane compounds having negative dielectric anisotropy
EP3874009B1 (fr) Dérivés de dibenzofurane et de dibenzothiophène
JP5456315B2 (ja) シクロブタンおよびスピロ［３．３］ヘプタン化合物類
US7417157B2 (en) Hexahydrodibenzofuran derivatives
US7575785B2 (en) Cyclopenta[a]naphthaline derivatives
EP3645662B1 (fr) Dérives du 2,3-dihydrobenzothiophène
US20030222243A1 (en) Fluorinated indenes and 1,7-dihydroindacenes of negative dielectric anisotrophy
WO2019052973A1 (fr) Dérivés de dibenzofurane et de dibenzothiophène
US7517471B2 (en) As-indacen derivatives
US6808762B2 (en) Oxabicyclooctanes
JPH0820777A (ja) ベンゼン誘導体及び液晶媒質
US8303844B2 (en) Benzo[f]chrome any pyrano[3,2-f]chrome derivatives for use in liquid crystal media
DE102008027972B4 (de) Naphthofuranderivate

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20191212

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20201104

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1374513

Country of ref document: AT

Kind code of ref document: T

Effective date: 20210415

Ref country code: DE

Ref legal event code: R096

Ref document number: 602018014432

Country of ref document: DE

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210624

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210625

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210624

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20210324

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1374513

Country of ref document: AT

Kind code of ref document: T

Effective date: 20210324

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210726

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210724

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602018014432

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

26N No opposition filed

Effective date: 20220104

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20210630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210625

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210630

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210625

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210724

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20220625

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220625

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230519

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20180625

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20240328

Year of fee payment: 7